par Meraviglia, S;Eberl, M;Vermijlen, David ;Todaro, M;Buccheri, S;Cicero, G;La Mendola, C;Guggino, G;D'Asaro, M;Orlando, V;Scarpa, F;Roberts, Allen;Caccamo, N;Stassi, G;Dieli, F;Hayday, A C
Référence Clinical and experimental immunology, 161, 2, page (290-297)
Publication Publié, 2010-08
Référence Clinical and experimental immunology, 161, 2, page (290-297)
Publication Publié, 2010-08
Article révisé par les pairs
Titre: |
|
Auteur: | Meraviglia, S; Eberl, M; Vermijlen, David; Todaro, M; Buccheri, S; Cicero, G; La Mendola, C; Guggino, G; D'Asaro, M; Orlando, V; Scarpa, F; Roberts, Allen; Caccamo, N; Stassi, G; Dieli, F; Hayday, A C |
Informations sur la publication: | Clinical and experimental immunology, 161, 2, page (290-297) |
Statut de publication: | Publié, 2010-08 |
Sujet CREF: | Immunologie |
Mots-clés: | cytokines |
cytotoxicity | |
immunotherapy | |
metastatic breast cancer | |
Vγ9Vδ2 T cells | |
MeSH keywords: | Adjuvants, Immunologic -- adverse effects -- pharmacology -- therapeutic use |
Aged | |
Antigens, CD27 -- metabolism | |
Antigens, CD45 -- metabolism | |
Breast Neoplasms -- blood -- immunology -- therapy | |
Cell Proliferation -- drug effects | |
Chemokines -- blood | |
Cytokines -- blood | |
Diphosphonates -- adverse effects -- pharmacology -- therapeutic use | |
Disease Progression | |
Esterases -- metabolism | |
Female | |
Hemiterpenes -- pharmacology | |
Humans | |
Imidazoles -- adverse effects -- pharmacology -- therapeutic use | |
Immunotherapy -- methods | |
Interferon-gamma -- metabolism | |
Interleukin-2 -- adverse effects -- pharmacology -- therapeutic use | |
Lymphocyte Activation -- drug effects | |
Lymphocyte Count | |
Lysine -- analogs & derivatives -- metabolism | |
Middle Aged | |
Mucin-1 -- blood | |
Organophosphorus Compounds -- pharmacology | |
Receptors, Antigen, T-Cell, gamma-delta -- metabolism | |
Remission Induction | |
Salvage Therapy | |
T-Lymphocyte Subsets -- cytology -- drug effects -- immunology -- metabolism | |
TNF-Related Apoptosis-Inducing Ligand -- metabolism | |
Treatment Outcome | |
Note générale: | Clinical Trial, Phase I |
Journal Article | |
Research Support, Non-U.S. Gov't | |
FLWIN | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0009-9104 |
info:doi/10.1111/j.1365-2249.2010.04167.x | |
info:pii/CEI4167 | |
info:scp/77954652637 | |
info:pmid/20491785 | |
PMC2909411 |